New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|November 1, 1997
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Type 2 Diabetes
- Volume 3
- Issue 10 Suppl
Roundtable Discussions - Diabetes Management Techniques
Advertisement
Articles in this issue
almost 29 years ago
Goals and Objectivesalmost 29 years ago
Participating Facultyalmost 29 years ago
Declaring War on Diabetes: New Strategies for Old Battlesalmost 29 years ago
Diabetes: New Insights, Innovative Approachesalmost 29 years ago
Roundtable Discussions - Diabetes Prevalence, Development and Progressionalmost 29 years ago
Selected Abstractsalmost 29 years ago
CME Quizalmost 29 years ago
BibliographyAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Treatment for Sanfilippo Syndrome Type A
2
Real-World Data: FACT vs Non-FACT CAR T Outcomes Compared
3
World Alzheimer Day: Young-Onset Alzheimer Disease Often Misdiagnosed
4
No Blood Biomarker Is Ready to Pick Psoriasis Therapy
5